Making Important Progress
The COVID-19 pandemic has been a critical turning point for infectious diseases (ID) in ageing adults. How to get the right preventive intervention against ID in the group that needs it the most, has been proven essential for public health needs. Today more than ever, VITAL is a necessary project that help indicate the right approach for implementing this prevention against ID in at-risk populations across Europe. Understanding and being able to measure the value of the optimal approach is most critical.
Some points the team is taken from the meeting regarding the evaluation framework development:
- Links to be made between frailty-level, type of infection, health care exposure, and age, with the vaccine immune response for their economic value assessment.
- Focus in the economic models should also be on ‘place of living’, ‘health condition’ and ‘easy implementation’ of new interventions like for vaccines.
- Challenge to develop a ‘one-model’ approach as it must include much diversity seen in this program.
- Complex approaches should be avoided as they may generate small added benefit and be difficult to assess because of limited data available in many environments